Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB (publ), a clinical stage pharmaceutical company, develops drugs to prevent serious neonatal diseases affecting premature infants in Sweden. The company's lead drug candidate is IBP-9414, which is in Phase III clinical studies `to prevent necrot...
Infant Bacterial Therapeutics AB Logo
About Infant Bacterial Therapeutics AB
Infant Bacterial Therapeutics AB is a pharmaceutical company. The Company develops drugs that meet the needs of premature infants. IBT has headquarters in Sweden.
Address
Bryggargatan 10,
Stockholm, 111 21
Sweden
Year founded
2011
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
